Skip to main content

S&P 500 ETF jumps 2% after hours on report Gilead drug showing effectiveness treating coronavirus

The ETF tracking the S&P 500 rallied after hours after a report said a Gilead drug was showing effectiveness in treating the coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.